Clinical Pharmacology and Drug Toxicity Practice Questions

Q: What is the antidote for magnesium sulfate (MgSO4)?

Calcium gluconate. **Explanation:** **Correct Answer: B. Calcium Gluconate** Magnesium sulfate ($MgSO_4$) is the drug of choice for preventing and treating seizures in eclampsia. However, it has a narrow therapeutic index. Magnesium acts as a physiological calcium channel blocker; when levels become toxic, it inhibits neuromuscular transmission by antagonizing calcium ions. **Calcium gluconate** (10 ml of 10% solution administered IV over 10 minutes) acts as a direct antagonist, rapidly reversing the cardiorespiratory depressive effects of magnesium toxicity. **Incorrect Options:** * **A. Vitamin K:** This is used to reverse the effects of Warfarin or to treat Vitamin K deficiency-related bleeding (e.g., Hemorrhagic disease of the newborn). * **C. Insulin and Dextrose:** This combination is the standard emergency treatment for **hyperkalemia**, as it shifts potassium from the extracellular to the intracellular compartment. * **D. Sodium Bicarbonate:** Used to treat metabolic acidosis, tricyclic antidepressant (TCA) overdose, or specific toxicities like aspirin; it has no role in reversing magnesium. **High-Yield Clinical Pearls for NEET-PG:** * **Therapeutic Range:** 4–7 mEq/L. * **Monitoring Toxicity (The "Rule of 3"):** 1. **Loss of Patellar Reflex (Knee jerk):** Earliest sign (occurs at 8–10 mEq/L). 2. **Respiratory Depression:** Occurs at >12 mEq/L. 3. **Cardiac Arrest:** Occurs at >25 mEq/L. * **Prerequisites for Administration:** Before giving the next dose of $MgSO_4$, always check for: * Presence of patellar reflex. * Respiratory rate >12/min. * Urine output >30 ml/hr (as Magnesium is excreted solely by the kidneys).

Q: All of the following conditions show hyperthermia, EXCEPT:

None of the above. ### Explanation The correct answer is **D (None of the above)** because all three conditions listed (Neuroleptic Malignant Syndrome, Phencyclidine use, and Aspirin toxicity) are well-recognized clinical causes of hyperthermia. **1. Neuroleptic Malignant Syndrome (NMS):** NMS is an idiosyncratic reaction to dopamine antagonists (e.g., Haloperidol). The pathophysiology involves central dopamine blockade in the hypothalamus, leading to a "reset" of the thermoregulatory set-point and severe muscle rigidity (lead-pipe rigidity). This combination results in life-threatening hyperthermia. **2. Phencyclidine (PCP) Use:** PCP is a dissociative anesthetic that causes psychomotor agitation, violent behavior, and seizures. Hyperthermia in PCP toxicity results from excessive muscular activity and increased metabolic rate. It is often associated with rhabdomyolysis. **3. Aspirin (Salicylate) Toxicity:** Salicylates act as **uncouplers of oxidative phosphorylation**. This process prevents the efficient production of ATP, causing the energy from the electron transport chain to be dissipated as heat instead of being stored as chemical energy. This leads to metabolic hyperpyrexia. --- ### High-Yield Clinical Pearls for NEET-PG: * **Malignant Hyperthermia:** Triggered by volatile anesthetics (Halothane) or Succinylcholine due to a mutation in the **RYR1 receptor**. Treatment of choice is **Dantrolene**. * **Serotonin Syndrome:** Often confused with NMS. Key differentiator: NMS has "lead-pipe" rigidity, while Serotonin Syndrome presents with **hyperreflexia and clonus**. * **Atropine Poisoning:** Causes hyperthermia ("Hot as a hare") due to the suppression of sweat gland activity (anhidrosis). * **Management Tip:** For severe hyperthermia (>106°F), physical cooling (ice water immersion) is prioritized over antipyretics like Paracetamol, which are ineffective in these toxidromes.

Q: Tacrolimus acts by inhibiting which of the following?

T-cell proliferation. ### Explanation **Correct Answer: C. T-cell proliferation** **Mechanism of Action:** Tacrolimus (FK506) is a potent **calcineurin inhibitor**. It works by binding to an intracellular protein called **FK-binding protein (FKBP-12)**. This complex then inhibits calcineurin, a phosphatase enzyme required for the activation of the transcription factor **NFAT** (Nuclear Factor of Activated T-cells). Without NFAT activation, the transcription of **Interleukin-2 (IL-2)** and other cytokines is blocked. Since IL-2 is the primary growth factor for T-lymphocytes, its absence prevents **T-cell activation and proliferation**, leading to immunosuppression. **Why other options are incorrect:** * **Option A:** Drugs like **Azathioprine** (purine synthesis inhibitor) and **Mycophenolate Mofetil** (IMPDH inhibitor) act by inhibiting DNA/RNA synthesis. Tacrolimus acts on signaling pathways, not direct nucleotide synthesis. * **Option B:** Anti-lymphocyte antibodies (like ATG or Muromonab-CD3) are exogenous proteins used for induction therapy; Tacrolimus does not inhibit the formation of these antibodies. * **Option D:** Since Tacrolimus is highly specific for the calcineurin-NFAT pathway, it does not broadly target all the mechanisms mentioned. **NEET-PG High-Yield Pearls:** * **Potency:** Tacrolimus is 10–100 times more potent than Cyclosporine. * **Side Effects:** Unlike Cyclosporine, Tacrolimus is **more likely to cause Post-Transplant Diabetes Mellitus (PTDM)** and neurotoxicity (tremors), but **less likely** to cause hirsutism or gum hyperplasia. * **Monitoring:** Therapeutic Drug Monitoring (TDM) is essential due to its narrow therapeutic index. * **Drug Interactions:** It is metabolized by **CYP3A4**; inhibitors (like Ketoconazole or Erythromycin) can lead to Tacrolimus toxicity.

Q: Which of the following chelating agents is a degradation product of Penicillin?

Penicillamine. **Explanation:** **Penicillamine** is the correct answer because it is a degradation product of **Penicillin**. Chemically, it is β,β-dimethylcysteine. It was first isolated from the urine of patients with liver disease who were receiving penicillin therapy. It contains a sulfhydryl (-SH) group that allows it to form stable, soluble complexes with heavy metals, which are then excreted by the kidneys. **Analysis of Options:** * **EDTA (Ethylene Diamine Tetra-acetic Acid):** A synthetic polyamino carboxylic acid. It is the primary chelator for **Lead poisoning** (given as Calcium Disodium EDTA to prevent hypocalcemia). * **Dimercaprol (BAL - British Anti-Lewisite):** A synthetic dithiol compound developed during WWII as an antidote for arsenic-based gas. It is used for **Arsenic, Mercury, and Lead** poisoning. * **Desferrioxamine:** A natural product derived from the bacterium *Streptomyces pilosus*. It is a specific siderophore used for **Acute Iron poisoning** and chronic iron overload (Thalassemia). **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** Penicillamine is the drug of choice for **Wilson’s Disease** (Copper poisoning) and is also used in Cystinuria and severe Rheumatoid Arthritis. * **Adverse Effects:** It is notorious for causing **nephrotic syndrome**, membranous glomerulonephritis, and skin elastolysis (Cutis laxa). * **Pyridoxine Deficiency:** Penicillamine acts as a Vitamin B6 antagonist; supplementation is often required during long-term therapy. * **Contraindication:** Avoid in patients with a history of penicillin allergy (cross-reactivity risk).

Q: What is the recommended dose of pralidoxime in organophosphate poisoning?

1-2 g IV. **Explanation:** **1. Why Option C is Correct:** Pralidoxime (2-PAM) is a **cholinesterase reactivator** used in organophosphate (OP) poisoning. OP compounds bind to the enzyme acetylcholinesterase (AChE), leading to a "cholinergic crisis." Pralidoxime works by removing the phosphate group from the enzyme, thereby regenerating active AChE [2, 3]. To achieve therapeutic plasma concentrations rapidly and reverse neuromuscular blockade (especially respiratory muscle paralysis), a high dose of **1-2 g administered via slow Intravenous (IV) infusion** (usually over 15–30 minutes) is required [1]. **2. Why Other Options are Incorrect:** * **Options A & B (1-2 mg):** This dose is far too low. 1-2 mg is the typical starting dose for **Atropine** in OP poisoning, not Pralidoxime. Confusing the milligram dose of atropine with the gram dose of oximes is a common examiner trap. * **Option D (Oral):** In acute OP poisoning, the patient often has altered sensorium, vomiting, or severe respiratory distress. Oral administration is too slow and unreliable for an emergency antidote. **3. High-Yield Clinical Pearls for NEET-PG:** * **The "Aging" Phenomenon:** Pralidoxime must be administered early (ideally within 24–48 hours). Once the enzyme-toxin bond "ages" (dealkylation), oximes can no longer reactivate the enzyme [2, 3]. * **Atropine vs. Oximes:** Atropine reverses **muscarinic** symptoms (miosis, bradycardia, secretions) but does **not** fix muscle weakness. Pralidoxime is essential to reverse **nicotinic** effects (muscle paralysis). * **Rule of Therapy:** "Atropinize" the patient first (dry secretions/clear lungs) before or alongside oxime administration. * **Contraindication:** Oximes are generally **not** recommended for Carbamate poisoning as the enzyme-carbamate bond reverses spontaneously and oximes may worsen toxicity in certain cases (e.g., Carbaryl).

Q: Which of the following is not used in the management of barbiturate poisoning?

Flumazenil. **Explanation:** The correct answer is **Flumazenil** because it is a specific competitive antagonist at the GABA-A receptor benzodiazepine (BZD) binding site. While both barbiturates and benzodiazepines enhance GABAergic neurotransmission, they act at different sites on the receptor. **Flumazenil does not antagonize barbiturates**; it is exclusively used for benzodiazepine overdose. **Analysis of Options:** * **Alkaline Diuresis:** This is a mainstay for long-acting barbiturates (e.g., Phenobarbital). Since phenobarbital is a weak acid, alkalinizing the urine with Sodium Bicarbonate ($NaHCO_3$) promotes its ionization, preventing renal tubular reabsorption and enhancing excretion (ion trapping). * **Hemodialysis:** This is indicated in severe barbiturate poisoning, especially when the patient is in deep coma, has renal failure, or when conservative management fails. It is highly effective for removing long-acting barbiturates. * **Activated Charcoal:** Multiple-dose activated charcoal (MDAC) is used to interrupt the enterohepatic and entero-gastric circulation of barbiturates, significantly increasing their clearance. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Death:** In barbiturate poisoning, death usually occurs due to **respiratory failure** or cardiovascular collapse. * **Barbiturate vs. BZD:** Barbiturates increase the *duration* of GABA-gated chloride channel opening, whereas BZDs increase the *frequency*. * **Contraindication:** Forced alkaline diuresis is **not** effective for short-acting barbiturates (e.g., Thiopental) because they are primarily metabolized by the liver, not excreted by the kidneys. * **Specific Antidote:** There is **no specific pharmacological antagonist** for barbiturates; management is primarily supportive.

Q: A 4-year-old child, who has been playing with painted toys for the past 2 years and habitually places them in their mouth, develops drowsiness, fever, constipation, and abdominal pain 6 hours after exposure. What is the treatment of choice for this condition?

EDTA + Dimercaprol. ### Explanation **Diagnosis: Acute Lead Encephalopathy** The clinical presentation of a child with a history of pica (mouthing painted toys), abdominal pain (lead colic), constipation, and neurological symptoms (drowsiness, fever) strongly suggests **Acute Lead Poisoning** with **Encephalopathy**. #### 1. Why EDTA + Dimercaprol is Correct In cases of **severe lead poisoning** (Blood Lead Levels >70 µg/dL) or when **encephalopathy** is present, a combination of two chelators is mandatory. * **Dimercaprol (BAL)** is given first because it can cross the blood-brain barrier and mobilize lead from the CNS. * **Ca-Na₂EDTA** is added 4 hours later to facilitate the excretion of the mobilized lead. * *Note:* BAL must be administered before EDTA to prevent EDTA from transiently increasing lead levels in the brain, which could worsen encephalopathy. #### 2. Why Other Options are Incorrect * **B. DMSA (Succimer):** This is the drug of choice for **asymptomatic** lead poisoning or moderate cases (BLL 45–69 µg/dL) without encephalopathy. It is administered orally. * **C. D-Penicillamine:** Used primarily for Wilson’s disease and sometimes as a third-line agent for lead poisoning, but it is not the treatment of choice for acute encephalopathy. * **D. BAL (Dimercaprol) alone:** While BAL is part of the regimen, it is insufficient on its own for lead; it must be combined with EDTA to ensure effective systemic clearance. #### 3. High-Yield Clinical Pearls for NEET-PG * **Lead Poisoning (Plumbism):** Look for "Burtonian lines" (bluish-purple gingival lines) and "Basophilic stippling" on peripheral blood smears. * **X-ray finding:** "Lead lines" at the metaphyses of long bones in children. * **Chelator of choice for other metals:** * **Iron:** Deferoxamine * **Copper/Wilson’s:** D-Penicillamine (or Trientine) * **Mercury/Arsenic:** Dimercaprol (BAL) or DMSA * **Iron Overload (Oral):** Deferasirox

Q: Vitamin B6 deficiency is seen with the use of all of the following drugs except:

Cyclosporine. **Explanation:** The correct answer is **Cyclosporine**. Vitamin B6 (Pyridoxine) deficiency occurs when drugs either interfere with its metabolic activation to Pyridoxal-5-Phosphate (PLP) or form complexes with it, leading to increased urinary excretion. **Why Cyclosporine is the correct answer:** Cyclosporine is a calcineurin inhibitor used as an immunosuppressant. Its primary toxicities are **nephrotoxicity**, hypertension, neurotoxicity (tremors), and gingival hyperplasia. It does **not** interfere with Vitamin B6 metabolism. **Why the other options are incorrect:** * **Isoniazid (INH):** This is the most classic cause. INH inhibits the enzyme *pyridoxine phosphokinase* and also reacts with PLP to form a hydrazone complex, which is excreted in the urine. This leads to peripheral neuropathy. * **Cycloserine:** An antitubercular drug that acts as a structural analog of D-alanine. It inhibits the enzymes that convert pyridoxine to its active form, often causing CNS side effects (seizures, psychosis) that are reversible with B6. * **D-Penicillamine:** Used in Wilson’s disease and rheumatoid arthritis, it chemically combines with pyridoxine to form a thiazolidine derivative, rendering the vitamin inactive and promoting its excretion. **NEET-PG High-Yield Pearls:** 1. **Hydralazine** (antihypertensive) is another high-yield drug that causes B6 deficiency and peripheral neuropathy. 2. **Clinical Presentation:** B6 deficiency typically manifests as **peripheral neuropathy**, sideroblastic anemia, and seborrheic dermatitis. 3. **Prophylaxis:** Patients on Isoniazid (especially those with diabetes, alcoholism, or malnutrition) should receive **10–50 mg/day** of Pyridoxine to prevent neuropathy. 4. **L-Dopa Interaction:** Pyridoxine increases the peripheral decarboxylation of L-Dopa, reducing its availability to the brain (unless combined with Carbidopa).

Q: In methyl alcohol poisoning, CNS depression, cardiac depression, and optic nerve atrophy occur. What are these effects due to?

Formaldehyde and formic acid. ### Explanation **Mechanism of Toxicity** Methyl alcohol (Methanol) itself is relatively non-toxic, causing only mild CNS depression. The severe clinical manifestations occur due to its **metabolism** in the liver. Methanol is oxidized by the enzyme **Alcohol Dehydrogenase (ADH)** into **Formaldehyde**, which is then rapidly converted by **Aldehyde Dehydrogenase (ALDH)** into **Formic Acid**. * **Formaldehyde:** Highly reactive and primarily responsible for initial cellular damage. * **Formic Acid:** The main culprit for systemic toxicity. It inhibits mitochondrial cytochrome c oxidase, leading to cellular hypoxia and **metabolic acidosis** (High Anion Gap). It specifically targets the **optic nerve** (causing retinal edema and atrophy) and the **basal ganglia** (putaminal necrosis). **Analysis of Incorrect Options** * **B. Acetaldehyde:** This is the primary metabolite of **Ethyl alcohol** (Ethanol). Accumulation of acetaldehyde (e.g., in Disulfiram reaction) causes flushing, tachycardia, and nausea, but not optic atrophy. * **C. Pyridine:** A basic heterocyclic organic compound used as a solvent; it is not a metabolite of methanol. * **D. Acetic acid:** This is the end-product of ethanol metabolism (formed from acetaldehyde). It is non-toxic and enters the Kreb’s cycle. **High-Yield Clinical Pearls for NEET-PG** 1. **Clinical Triad:** CNS depression, severe metabolic acidosis, and visual disturbances ("snowstorm vision"). 2. **Antidote of Choice:** **Fomepizole** (inhibits Alcohol Dehydrogenase). 3. **Alternative Antidote:** **Ethanol** (has a higher affinity for ADH, preventing methanol breakdown). 4. **Adjuvant Therapy:** **Folate/Leucovorin** is administered to enhance the breakdown of formic acid into $CO_2$ and $H_2O$. 5. **Imaging:** MRI may show characteristic **bilateral putaminal necrosis**.

Question 1

What is the antidote for magnesium sulfate (MgSO4)?

Accepted Answer

Calcium gluconate

Answer

Vitamin K

Answer

Insulin and dextrose

Answer

Sodium bicarbonate (NaHCO3)

Question 2

All of the following conditions show hyperthermia, EXCEPT:

Accepted Answer

None of the above

Answer

Neuroleptic malignant syndrome

Answer

Phencyclidine use

Answer

Aspirin toxicity

Question 3

Tacrolimus acts by inhibiting which of the following?

Accepted Answer

T-cell proliferation

Answer

DNA and RNA synthesis

Answer

Anti-lymphocyte antibody formation

Answer

All of the above

Question 4

Which of the following chelating agents is a degradation product of Penicillin?

Accepted Answer

Penicillamine

Answer

EDTA

Answer

Dimercaprol

Answer

Desferrioxamine

Question 5

What is the recommended dose of pralidoxime in organophosphate poisoning?

Accepted Answer

1-2 g IV

Answer

1-2 mg IV

Answer

1-2 mg IM

Answer

1-2 g oral

Question 6

Which of the following medications can cause erectile dysfunction?

Accepted Answer

Antihistamines

Answer

Leukotriene antagonists

Answer

Thyroxine

Answer

Insulin glargine

Question 7

Which of the following is not used in the management of barbiturate poisoning?

Accepted Answer

Flumazenil

Answer

Alkaline diuresis

Answer

Hemodialysis

Answer

Activated charcoal

Question 8

A 4-year-old child, who has been playing with painted toys for the past 2 years and habitually places them in their mouth, develops drowsiness, fever, constipation, and abdominal pain 6 hours after exposure. What is the treatment of choice for this condition?

Accepted Answer

EDTA + Dimercaprol

Answer

DMSA

Answer

D-Penicillamine

Answer

BAL

Question 9

Vitamin B6 deficiency is seen with the use of all of the following drugs except:

Accepted Answer

Cyclosporine

Answer

Cycloserine

Answer

Isoniazid

Answer

D-Penicillamine

Question 10

In methyl alcohol poisoning, CNS depression, cardiac depression, and optic nerve atrophy occur. What are these effects due to?

Accepted Answer

Formaldehyde and formic acid

Answer

Acetaldehyde

Answer

Pyridine

Answer

Acetic acid

Clinical Pharmacology and Drug Toxicity — MCQs

Clinical Pharmacology and Drug Toxicity — MCQs

On this page

Practice by Chapter

Want unlimited practice?